AVKARE LLC: Drug Recall
Recall #D-0091-2023 · 12/22/2022
Class II: Risk
Recall Details
- Recall Number
- D-0091-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AVKARE LLC
- Status
- Completed
- Date Initiated
- 12/22/2022
- Location
- Pulaski, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1237 cartons
Reason for Recall
Failed impurities/degradation specifications: Out of specification for unknown impurities.
Product Description
Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15
Distribution Pattern
USA Nationwide
Other Recalls by AVKARE LLC
- Class II: Risk 08/11/2023
- Class II: Risk 08/11/2023
- Class III: Low Risk 06/13/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.